EP1133459 - Bibliographic data

SERTRALINE HYDROCHLORIDE FORM V

Last update	12/07/2025
Legal status	Brevet déchu
Origin	Euro-PCT

(73) Holder	TEVA PHARMACEUTICAL INDUSTRIES LTD. 5 Basel Street, P.O. Box 3190 49131 Petah Tiqva Israël
(72) Inventors	SCHWARTZ, Eduard Remez 70 Rechovot Israël NIDAM, Tamar Rechov Weizman 53/40 Yehud Israël LIBERMAN, Anita Rechov Ben-Joseph 28 Tel-Aviv Israël MENDELOVICI, Marioara Rechov Hadar 6/12 Rechovot Israël ARONHIME, Jehudit 9 Havalutzky Street 44242 Kfar Saba Israël SINGER, Claude 8 David Elazar Street Kfar Saba Israël VALDMAN, Evgeni 3 Hamakabim Street Petah Tikva Israël
(74) Agent	Mail recipient NACHSHEN, NEIL JACOB ET AL D Young & Co LLP 120 Holborn EC4A 1DA LONDON Royaume-Uni

(21) Request number	EP99959091.2
(22) Request date	24/11/1999

(11) Publication number	EP1133459
Publication date	11/01/2006

(54) Title of the invention	SERTRALINE HYDROCHLORIDE FORM V
(51) International classification	C07C 1/00, C07C 211/42, C07C 209/84
International classification (before reform)	None

Claimed priority	(31) Number: 110113 P (32) Date: 27/11/1998 (33) Country: US (31) Number: 125172 P (32) Date: 19/03/1999 (33) Country: US (31) Number: 133117 P (32) Date: 07/05/1999 (33) Country: US (31) Number: 147888 P (32) Date: 09/08/1999 (33) Country: US
Initial application	None
Divisional application	None

Expected annuity	Annuity: 8 - Amount: 96 € - Due date 30/11/2006 Surtax: 8 - Amount: 19.2 € - Due date 31/05/2007
Last annuity	None

Publication	BREVETS D'INVENTION DESIGNANT MC DELIVRES PAR l'OEB - bulletin 2006/1, of 31/03/2006
History	Publication de la délivrance du brevet européen - Legal date 11/01/2006 Déchéance du brevet d'invention après période de grâce - Legal date 30/11/2006 Entrée en période de grâce du brevet d'invention - Legal date 30/11/2006